289 related articles for article (PubMed ID: 21865721)
1. Role of nontypeable Haemophilus influenzae in otitis media and chronic obstructive pulmonary disease.
Thanavala Y; Lugade AA
Adv Otorhinolaryngol; 2011; 72():170-5. PubMed ID: 21865721
[TBL] [Abstract][Full Text] [Related]
2. The adhesins of non-typeable Haemophilus influenzae.
Osman KL; Jefferies JM; Woelk CH; Cleary DW; Clarke SC
Expert Rev Anti Infect Ther; 2018 Mar; 16(3):187-196. PubMed ID: 29415569
[TBL] [Abstract][Full Text] [Related]
3. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
Bertot GM; Becker PD; Guzmán CA; Grinstein S
J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
[TBL] [Abstract][Full Text] [Related]
4. Why we need a vaccine for non-typeable Haemophilus influenzae.
Cerquetti M; Giufrè M
Hum Vaccin Immunother; 2016 Sep; 12(9):2357-61. PubMed ID: 27171854
[TBL] [Abstract][Full Text] [Related]
5. Nontypeable Haemophilus influenzae as a pathogen in children.
Murphy TF; Faden H; Bakaletz LO; Kyd JM; Forsgren A; Campos J; Virji M; Pelton SI
Pediatr Infect Dis J; 2009 Jan; 28(1):43-8. PubMed ID: 19057458
[TBL] [Abstract][Full Text] [Related]
6. Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease.
Alikhan MM; Lee FE
Curr Opin Pulm Med; 2014 Mar; 20(2):159-64. PubMed ID: 24441573
[TBL] [Abstract][Full Text] [Related]
7. Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease.
Eldika N; Sethi S
Curr Opin Pulm Med; 2006 Mar; 12(2):118-24. PubMed ID: 16456381
[TBL] [Abstract][Full Text] [Related]
8. Respiratory infections caused by non-typeable Haemophilus influenzae.
Murphy TF
Curr Opin Infect Dis; 2003 Apr; 16(2):129-34. PubMed ID: 12734445
[TBL] [Abstract][Full Text] [Related]
9. Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.
Sriram KB; Cox AJ; Clancy RL; Slack MPE; Cripps AW
Crit Rev Microbiol; 2018 Mar; 44(2):125-142. PubMed ID: 28539074
[TBL] [Abstract][Full Text] [Related]
10. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease.
Berenson CS; Garlipp MA; Grove LJ; Maloney J; Sethi S
J Infect Dis; 2006 Nov; 194(10):1375-84. PubMed ID: 17054066
[TBL] [Abstract][Full Text] [Related]
11. The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
Su YC; Jalalvand F; Thegerström J; Riesbeck K
Front Immunol; 2018; 9():2530. PubMed ID: 30455693
[TBL] [Abstract][Full Text] [Related]
12. Burden and cost of hospital admissions for vaccine-preventable paediatric pneumococcal disease and non-typable Haemophilus influenzae otitis media in New Zealand.
Milne RJ; Vander Hoorn S
Appl Health Econ Health Policy; 2010; 8(5):281-300. PubMed ID: 20804222
[TBL] [Abstract][Full Text] [Related]
13. Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.
Khan MN; Ren D; Kaur R; Basha S; Zagursky R; Pichichero ME
Expert Rev Vaccines; 2016 Jul; 15(7):863-78. PubMed ID: 26894630
[TBL] [Abstract][Full Text] [Related]
14. Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media.
Langereis JD; Stol K; Schweda EK; Twelkmeyer B; Bootsma HJ; de Vries SP; Burghout P; Diavatopoulos DA; Hermans PW
mBio; 2012; 3(4):e00079-12. PubMed ID: 22761391
[TBL] [Abstract][Full Text] [Related]
15. Anti-EF-Tu IgG titers increase with age and may contribute to protection against the respiratory pathogen Haemophilus influenzae.
Thofte O; Kaur R; Su YC; Brant M; Rudin A; Hood D; Riesbeck K
Eur J Immunol; 2019 Mar; 49(3):490-499. PubMed ID: 30566236
[TBL] [Abstract][Full Text] [Related]
16. EF-Tu From Non-typeable
Thofte O; Su YC; Brant M; Littorin N; Duell BL; Alvarado V; Jalalvand F; Riesbeck K
Front Immunol; 2018; 9():2910. PubMed ID: 30619274
[TBL] [Abstract][Full Text] [Related]
17. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.
McMahon M; Murphy TF; Kyd J; Thanavala Y
Vaccine; 2005 May; 23(27):3590-6. PubMed ID: 15855018
[TBL] [Abstract][Full Text] [Related]
18. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
[TBL] [Abstract][Full Text] [Related]
19. Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.
King PT; Lim S; Pick A; Ngui J; Prodanovic Z; Downey W; Choong C; Kelman A; Baranyai E; Francis M; Moshinsky R; Bardin PG; Holmes PW; Holdsworth SR
J Allergy Clin Immunol; 2013 May; 131(5):1314-21.e14. PubMed ID: 23142009
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
Murphy TF
Clin Vaccine Immunol; 2015 May; 22(5):459-66. PubMed ID: 25787137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
